Kusajili – Clinical trials directory

Result of your search per sponsor: Cell Therapeutics Europe S.r.l

Woman Max 99 years
Cell Therapeutics Europe S.r.l Update Il y a 4 ans

Phase II open label study of CT-2106 as a single agent in patients with advanced metastatic ovarian cancer who have failed one prior platinum and taxane based regimen To determine the overall response rate (complete plus partial response) of CT-2106 in patients with advanced ovarian cancer who have failed one prior platinum and taxane based regimen.

Country None
organs None
Specialty None

unknown

More information